Free shipping on all orders over $ 500

 About 1 result found for searched term "609799-22-6" (0.126 seconds)

Cat.No.  Name Target
M8769 Tasimelteon Melatonin Receptor
BMS-214778; VEC-162
Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep–wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light–dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep–wake schedules.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.